This website uses technical, customisation and analytical cookies, both first-party and third-party, to anonymously facilitate browsing and analyse statistics on use of the website. Learn more
Search results
-
Square, Inc. IPO
Nanda, Ramana; White, Robert; Pickle, Lauren G.Case HBS-817054-EFinanceIn November 2015, Square, Inc. launched its initial public offering (IPO). The IPO had an offering price of $9 per share, lower than the $11 to $13 estimate that had been outlined in the preliminary prospectus and 42% below the $15.50 share price in its most recent financing less than a year before. The lower than anticipated pricing of Square's IPO, and the implied valuation, had left investors and market observers wondering if this was an indic...Starting at €8.20
-
Entrepreneurial Finance Problem Set
Nanda, Ramana; Sahlman, William A.; White, RobertCase HBS-817037-EFinanceStarting at €8.20
-
Dovernet, Teaching Note
Simons, Robert L.; Kindred, NatalieTeaching Note HBS-113011-EAccounting and ControlTeaching Note for 112061.Starting at €0.00
-
AngelList, Teaching Note
Nanda, RamanaTeaching Note HBS-815051-EEntrepreneurshipTeaching note for case 814036.Starting at €0.00
-
PAREXEL International Corp.: Stages of Innovation, Teaching Note
Herzlinger, Regina E.; Kindred, NatalieTeaching Note HBS-312057-ETeaching Note for 311-068 and 311-087.Starting at €0.00
-
Dovernet
Simons, Robert L.; Kindred, NatalieCase HBS-112061-EAccounting and ControlThis case illustrates the implications of using stringent performance measurement systems to create performance pressure, motivate employee achievement, and sharpen a firm's competitiveness. It opens by describing the downsides of the ruthlessly competitiStarting at €8.20
-
Merck: Managing Vioxx (A)
Simons, Robert L.; Rosenberg, Kathryn; Kindred, NatalieCase HBS-109080-EKnowledge and CommunicationThis two-class case series allows students to stand in the shoes of CEO Ray Gilmartin during the unfolding stages of a reputational crisis. Merck's mission statement claims to "put patients first," but the company is widely criticized for putting profit bStarting at €8.20